Kavita Patel, MD, fellow in economic studies and managing director at Brookings Institution, discussed how the cost of drugs should be accounted for in the total cost of care, and the importance of considering patient needs when offering drugs.
Kavita Patel, MD, fellow in economic studies and managing director at Brookings Institution, discussed how the cost of drugs should be accounted for in the total cost of care, and the importance of considering patient needs when offering drugs.
Transcript (slightly modified)
How can we bring accountable care to oncology with the cost of drugs as high as they currently are?
So the cost of drugs is pretty important, but they should not necessarily dominate the entire framework of “accountable care.” I think that the way to think about the cost of drugs is to actually incorporate them into the total cost of care, which has been an issue largely because drugs, or the delivery of drugs through pharmaceutical benefit management services, have sometimes been carved out when we talk about cost.
We talk a lot about hospitals or physician fees. In oncology, though, because we deliver drugs at the bedside or when the physician sees a patient, it can be a very different issue. So I think the more important piece is not excluding the drugs from the cost of care, but then also looking at how much the drug costs.
And it’s not just about how much the drug costs, it’s also how much is that drug in relationship to what we think the patient really values. If this is a drug that can help the patient accomplish their goals, personally, of living another year because they have certain milestones they want to achieve, then that should be taken into consideration as well.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen